Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia

Clin Pharmacokinet. 2017 Apr;56(4):421-433.
Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, Russu A.
CNSJournalPharmacometrics

Pharmetheus Affiliates

Portrait-of-Mats-Magnusson_Pharmetheus
Chief Operations Officer

Mats Magnusson

See bio
Portrait-of-Elodie-Plan_Pharmetheus-1
Chief Business Development Officer & Deputy CEO

Elodie Plan

See bio
Portrait-of-Niclas-Jonsson-Pharmetheus
Scientific Director & Pharmacometrics Platform Scientific Lead

Niclas Jonsson

See bio